Russell Z. Szmulewitz to Cohort Studies
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Cohort Studies.
Connection Strength
0.056
-
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC). J Immunother Cancer. 2021 08; 9(8).
Score: 0.030
-
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors. Clin Cancer Res. 2019 11 01; 25(21):6309-6319.
Score: 0.026